AUPH vs PG · P/E 28, rev $283.1M vs P/E 25, rev $84.28B
Aurinia Pharmaceuticals Inc (AUPH) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the AUPH and PG stock pages for the full models.
Not investment advice.